ArticleJournal of medicinal chemistry2009

Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.

Igor Nudelman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.